Answering human papillomavirus vaccine concerns; a matter of science and time

David Hawkes, Candice Harris, M Berryman

    Research output: Contribution to journalReview articlepeer-review

    6 Citations (Scopus)


    Since the introduction of the HPV vaccine, questions have been asked about its efficacy in preventing cancer linked with HPV. Concerns about the HPV vaccine safety profile have also been raised. This paper highlights the rapidly growing body of evidence (including clinical trials and post-marketing surveillance) illustrating both the safety of the HPV vaccine, through a detailed investigation of reported adverse events, and its efficacy in reducing both HPV infections rates and the resulting drop in cervical lesions, which have been demonstrated to be good predictors of cervical cancer risk.

    Original languageEnglish
    Article number22
    Number of pages8
    JournalInfectious Agents and Cancer
    Issue number1
    Publication statusPublished - 2013


    • Adverse events
    • Cancer prevention
    • Cervical cancer
    • Clinical trials
    • HPV
    • Human papillomavirus
    • Safety


    Dive into the research topics of 'Answering human papillomavirus vaccine concerns; a matter of science and time'. Together they form a unique fingerprint.

    Cite this